These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Changes in menstrual and haematological indices among Norplant acceptors. Aisien AO, Sagay AS, Imade GE, Ujah IA, Nnana OU. Contraception; 2000 Apr; 61(4):283-6. PubMed ID: 10899486 [Abstract] [Full Text] [Related]
7. Study of the effects of the implantable contraceptive Norplant on lipid and lipoprotein metabolism. UN Development Programme/UN Population Fund/WHO/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-Acting Systemic Agents for Fertility Regulation. Contraception; 1999 Jan; 59(1):31-45. PubMed ID: 10342084 [Abstract] [Full Text] [Related]
16. The effect of levonorgestrel intrauterine system on uterine myomas: a 1-year follow-up study. Gunes M, Ozdegirmenci O, Kayikcioglu F, Haberal A, Kaplan M. J Minim Invasive Gynecol; 2008 Apr; 15(6):735-8. PubMed ID: 18971138 [Abstract] [Full Text] [Related]
17. [Tolerance and acceptability of Norplant contraceptive devices]. Ba MG, Moreau JC, Diadhiou F. J Gynecol Obstet Biol Reprod (Paris); 2002 Dec; 31(8):765-71. PubMed ID: 12592196 [Abstract] [Full Text] [Related]
18. Increased serum levels of nitric oxide metabolites among users of levonorgestrel-releasing implants [corrected] a possible role in progestin-induced bleeding. Shaamash AH, Zakhari MM. Hum Reprod; 2005 Jan; 20(1):302-6. PubMed ID: 15471931 [Abstract] [Full Text] [Related]